INSIDE THE CURRENT ISSUE

October 2009

Products & Services


 

New Technology

New portable breath tester detects lung cancer

Scientists in Israel have devised a portable breath tester that detects lung cancer with 86 percent accuracy, according to a study. The device could provide an early warning system that flags the disease before tumors become visible in X-rays, the researchers reported in the journal Nature Nanotechnology.

The sensor uses gold nanoparticles to detect levels of so-called volatile organic compounds (VOC) — measured in a few parts per billion — that become more elevated in cancer patients. Early detection of lung cancer dramatically increases the odds of survival. Currently, only 15 percent of cases are discovered before the disease has begun to spread. Screening via computerized tomography (CT) or chest x-rays can reduce lung cancer deaths, but is expensive and exposes patients to undesirable radiation.

In the study, a team of researchers lead by Hossam Haick of the Israel Institute of Technology took breath samples from 56 healthy people and 40 lung cancer patients.

To avoid contaminants, participants repeatedly filled their lungs to capacity for five minutes through a filter that removed 99.99 percent of organic compounds from the air, a process called "lung washout". Then the scientists hunted for VOCs present only in the cancer patients that could serve as biomarkers for the disease. They found 33 compounds that appeared in at least 83 percent of the cancer group, but in fewer than 83 percent of the control group.

3M introduces first electronic stethoscope with wireless bluetooth

Taking the stethoscope into the 21st century, 3M announced the introduction of the 3M Littmann Electronic Stethoscope Model 3200, a next-generation auscultation device featuring Bluetooth technology that wirelessly transfers heart, lung and other body sounds to software for further analysis.

The company partnered with Connecticut-based Zargis Medical to develop two companion software packages exclusively for the Littmann Electronic Stethoscope Model 3200. Specifically: Zargis Cardioscan software easily pairs with the Littmann Electronic Stethoscope Model 3200 to guide the clinician through four main cardiac sites, then after approximately one minute, indicates whether or not the patient possesses a suspected diastolic or systolic murmur—and whether or not the murmur is suspected to be a Class I indication for echocardiography referral.

Eighty-three percent of cardiologists reported that it was easier to detect/hear an S3 gallop with a Littmann Electronic Stethoscope Model 3000 Series. More information on the Littmann Electronic Stethoscope 3000 Series, including a free 14-day
trial can be found at www.Littmann.com.

Watching your hospital’s burgeoning waste line

Stericycle expands reach into strategic growth areas

by Rick Dana Barlow

Call what the medical waste management market experienced during the last two decades as nothing less than a seismic shift and you’d classify the momentum rather accurately.

Going back to the late 1980s and early 1990s, hospitals faced feverish fallout for operating on-site incinerators with neighborhood protests loosely organized under the "Not In My Backyard" or NIMBY banner.

In response, the federal government issued more stringent emissions regulations that forced many hospitals to close their incinerators in favor of alternative treatment and disposal methods and technologies, such as autoclaving, electro-thermal deactivation (ETD) and microwaving. Treated medical waste then could be hauled off-site. Or hospitals simply chose to outsource treatment and disposal to companies offering those services.

Meanwhile, the competitive landscape among treatment and disposal companies navigated through the same consolidation wave as the hospital and healthcare supplier markets in the high-flying, healthcare reform-minded mid-1990s. Chief among the big corporate moves at the time: The fourth-largest solid waste management services company, Allied Waste Industries Inc., agreed to acquire Browning-Ferris Industries Inc., the No. 2 player in the market that also served as the market leader in medical waste treatment and disposal services.

But Allied, which adopted BFI’s more recognizable branding, wanted nothing to do with the healthcare industry.

Enter Stericycle Inc., a growing player in the healthcare market with its ETD technology, that acquired the BFI division and ultimately crowned itself king of medical waste management. It’s a title Stericycle still holds as it continues to acquire other companies, the latest of which is privately held MedServ.

Amid the closing at press time, Healthcare Purchasing News Senior Editor Rick Dana Barlow pitched a series of queries about industry trends to Debra Gillmeister, Stericycle’s director of marketing for large quantity healthcare services. With her clinical background, her experience as a former advisory board member for the American Hospital Association’s American Society for Healthcare Environmental Services and her MBA in finance, Gillmeister fielded the questions with aplomb and authority.

HPN: Ten years ago, disposal methods seemed to dominate the debate about managing medical waste. If you could encapsulate your impressions from a 30,000-foot view, how has the industry changed in the last decade?

Debra Gillmeister

GILLMEISTER: There are several trends related to hospitals looking for ways to be green. Green teams are forming in hospitals across the country. From our experience, a significant percentage of hospitals have established or are moving to initiate green programs that include clinical and non-clinical members. Often these responsibilities start out as supplementary, but more and more we are seeing dedicated full time ‘green’ staff. Leadership knows that it’s the right thing to do and is beginning to acknowledge that these efforts enhance the hospital’s image in the community. But it is challenging for hospitals to meet the Leadership in Energy and Environmental Design (LEED) criteria. Only 73 healthcare facilities of [American Hospital Association’s] nearly 5,000, or roughly 1.5 percent, have achieved LEED certification. Additional efforts to be green include hospitals using reusable sharps containers, such as Bio Systems, and finding ways to keep drugs out of the water. Essentially, we are seeing more programs that protect the environment and benefit hospital staff, patients and visitors.

Against the backdrop of "Not In My Backyard" or "NIMBY" protests back then, the discussions simmered around autoclaving vs. incineration, with alternative options like Stericycle’s electro-thermal deactivation (ETD) technology inserted into the mix to compete with costly hauling services. In your opinion, how far has the healthcare industry progressed or regressed since that time and why?

[Environmental Protection Agency] regulations are designed to protect the environment. Ten years ago, according to the EPA, there were 2,400 medical waste incinerators in the U.S. with the goal to reduce this number by 50 percent to 80 percent by 2010. Much progress has been made towards that goal with hundreds of on-site hospital incinerators being shut down. This is because it is more difficult for a hospital to maintain this type of investment and to meet additional regulations. Newly proposed EPA regulations will make it harder to continue operating incinerators. Just this year, we are aware of 11 Midwestern and Northeastern hospital incinerators which have been or are pending shutdown. However, for certain types of waste, incineration at a specialized dedicated facility is required based on the regulations and state requirements.

How would you characterize Stericycle’s competitive landscape today, compared to a decade ago?

Competition is ever-present in the business. With over 250 competitors across the country and with the advent of greener offerings, more companies are jumping on the bandwagon. This is why we have expanded our service offerings to include not only our Sharps Management Service but our Pharmaceutical Waste Compliance Service.

How do you move discussions about effective and efficient waste management strategies beyond the seemingly endless debate over reusable vs. disposable products?

Stericycle’s Sharps Management Service using Bio Systems reusable sharps containers was introduced in 1986. By September 2009, more than 70 million disposable containers have been kept out of landfills due to this service. This is equal to more than 6 million gallons of gasoline not being burned since the program started. Stericycle now offers tools like the Carbon Footprint Estimator for hospitals to measure their diminished carbon footprint. This tool is made available to any curious and conscientious hospital that wants to become more aware of their carbon footprint. No password is required for a hospital to use the tool. A Stericycle customer measures their diminished environmental impact based on actual container utilization, while a non-customer would obtain an estimate of what their diminished footprint could be. For example, an average 200-bed acute care hospital will divert more than 13,000 pounds of CO2 or equal to the emission from 679 gallons of gasoline. Again, having green initiatives makes a difference to staff, patients and the community.

(Editor’s Note: To access the Carbon Footprint Estimator, click on http://www.stericycle.com/carbon-footprint-calculator.html.)

A few years ago, Stericycle was hopeful and optimistic that demand for recycling and reuse would increase over time. Has that happened according to expectations and market projections with the popular green movement?

We believe that the green movement is growing. From our perspective, by keeping 70 million-plus reusable sharps containers out of landfills, a significant positive impact on the environment has occurred. This is the equivalent to preventing CO2 from going into the atmosphere that would be generated by a 25-mpg car circling the earth 10 times.

While effective products for safely treating and disposing fluid medical waste have been on the market for many years, the latest hot-button issue centers on untreated pharmaceutical waste ending up in the water supply to the extent that a growing number of hospitals are implanting drug waste management programs. Given the long history of waste management debate over solid, liquid and hazardous medical waste treatment and disposal, how did the idea of drugs as a waste product fly under the radar for so long? Who, if anyone, dropped the ball here?

We agree it is a complicated issue that has flown under the radar. [The Resource Conservation and Recovery Act] has been around for 30-plus years and was originally targeted to industrial and manufacturing processes. Until pharmaceuticals started being detected in drinking water the issue was not apparent, especially at the hospital level, even though best practices would suggest that appropriate segregation and treatment of pharmaceutical waste is required. Today, Stericycle has a solution for this issue. Our Pharmaceutical Waste Compliance service offers a sustainable solution. Our turn-key service categorizes a hospital formulary, trains staff to properly segregate pharmaceutical waste and then insures that the waste is appropriately transported and treated.

What kind of behavioral modification is needed for healthcare facilities to treat and/or dispose of drugs as they would solid, liquid and hazardous medical waste?

Training is critical and can be very complex. Stericycle’s national team of healthcare compliance specialists train hospital staff over a two-to-three day period. Included in this training is pharmacy, nursing, nurse educators, environmental services, facilities and anyone who handles pharmaceutical waste. Hospitals are slowly becoming aware and changing their clinical practices because of RCRA, programs like Stericycle’s and state legislation. For example, Illinois Gov. Pat Quinn recently signed several key environmental bills including one that dictates that by Jan. 1, 2010, healthcare institutions are prohibited from flushing or dumping unused medications into public wastewater. The practice of disposing of pharmaceuticals down the drain or in the toilet – excluding saline and dextrose – whether hazardous or not, is not a clinical best practice.

What are the average costs to treat and dispose solid, liquid and hazardous medical waste and how does the average cost to dispose of drug waste compare to that?

Treating hazardous waste is more expensive due to the fact that only a few incinerators across the country can handle this type of waste because of the more stringent emission requirements. Each year more and more regulations, especially at the state level, are being enacted that require appropriate segregation, transportation and treatment of pharmaceutical waste. This makes it more challenging to be compliant with the regulators. However, if pharmaceutical waste is properly segregated only about 10 percent should be classified as hazardous. Proper classification and segregation are two ways costs can be minimized.

Faced with a sour economy, tighter budgets and stiffer liabilities and penalties, how does a healthcare facility realistically keep costs in check to treat and dispose solid, liquid and hazardous medical waste, including pharmaceuticals?

It is not so much the cost but the cost avoidance that is important to a facility by maintaining best practices and having a waste segregation and waste minimization program in place. Consider fines such as $37,500 per violation per day that are levied by the EPA due to RCRA and $100,000 per violation that is issued by the Department of Transportation. Negative press regarding a violation can reflect on clinical practice and translate into fewer patient admissions. Doctors have a choice of where to admit their patients. Patients are becoming more educated consumers with regard to their medical treatment.

Watching your hospital’s burgeoning waste line

Reprocessing fuels green strategies